DAVID A. LOVEJOY
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Protagenic Therapeutics, Inc.\new
Filing Date
Source Excerpt
2025-03-10
David A. Lovejoy 144,275(7) 3 %
Data sourced from SEC filings. Last updated: 2026-03-05